A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.

Oral daily and weekly bisphosphonates represent the current mainstay of treatment for postmenopausal osteoporosis (PMO). However, the inconvenience of frequent dosing is known to negatively affect adherence to therapy in the long term. This has prompted the development of convenient oral bisphosphon...

Полное описание

Библиографические подробности
Главные авторы:	Reginster, J, Felsenberg, D, Cooper, C, Stakkestad, J, Miller, P, Kendler, D, Adami, S, McClung, MR, Bolognese, M, Civitelli, R, Dumont, E, Bonvoisin, B, Recker, R, Delmas, P
Формат:	Journal article
Язык:	English
Опубликовано:	2006

Схожие документы

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
по: Miller, P, и др.
Опубликовано: (2005)

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.
по: Reginster, J, и др.
Опубликовано: (2006)

The mobile study long-term extension: Progressive improvements in efficacy with oral ibandronate (150mg) when administered monthly
по: Reginster, J, и др.
Опубликовано: (2007)

Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
по: Richard Derman, и др.
Опубликовано: (2009-09-01)

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.
по: Cranney, A, и др.
Опубликовано: (2009)

Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.
по: Bauss, F, и др.
Опубликовано: (2004)

VIBE: Evaluation of Ibandronate Efficacy - Original Investigation
по: J-Y Reginster, и др.
Опубликовано: (2008-12-01)

VIBE: Evaluation of Ibandronate Efficacy - Original Investigation
по: J-Y Reginster, и др.
Опубликовано: (2008-12-01)

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
по: Shipman, C, и др.
Опубликовано: (2000)

Administration of bisphosphonate (ibandronate) impedes molar tooth movement in rabbits: A radiographic assessment
по: V Venkataramana, и др.
Опубликовано: (2014-01-01)

Ibandronate: pharmacology and preclinical studies.
по: Russell, R
Опубликовано: (2006)

First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
по: Vishal R Tandon, и др.
Опубликовано: (2014-01-01)

Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis.
по: Cooper, C, и др.
Опубликовано: (2003)

Review of once-monthly oral ibandronate and the use thereof
по: T De Villiers, и др.
Опубликовано: (2017-08-01)

Efficacy of generic alendronate and ibandronate in post menopausal osteoporosis
по: NP Somasundaram, и др.
Опубликовано: (2012-03-01)

Inhibitory actions by ibandronate sodium, a nitrogen-containing bisphosphonate, on calcium-activated potassium channels in Madin–Darby canine kidney cells
по: Sheng-Nan Wu, и др.
Опубликовано: (2015-01-01)

A reappraisal of generic bisphosphonates in osteoporosis.
по: Kanis, J, и др.
Опубликовано: (2012)

Intermittent intravenous ibandronate therapy for osteoporosis
по: L I Alekseeva, и др.
Опубликовано: (2008-09-01)

Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
по: Cooper, C, и др.
Опубликовано: (2001)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
по: Oliver Bock, и др.
Опубликовано: (2008-06-01)

Skeletal responses to romosozumab after 12 months of denosumab
по: Michael R. McClung, и др.
Опубликовано: (2021-07-01)

Pain control with ibandronate for bone marrow oedema of the knee
по: Livia Küchler, и др.
Опубликовано: (2020-11-01)

Oral Ibandronate Therapy in Three Patients with Osteogenesis Imperfecta
по: Štěpán Kutílek, и др.
Опубликовано: (2021-11-01)

EFFECT OF ZOLEDRONIC AND IBANDRONIC ACIDS ON BONE METABOLISM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
по: O V Yakushevskaya, и др.
Опубликовано: (2012-08-01)

Podocyte Disease Following Treatment with Intravenous Ibandronate in an Older Patient
по: Ye Rin Chung, и др.
Опубликовано: (2024-06-01)

Efficiency of Ibandronate in Monotherapy and in Combination with Alfacalcidol in Women with Postmenopausal Osteoporosis
по: S.I. Ismailov, и др.
Опубликовано: (2016-09-01)

Combined Use of Ibandronate and Eldecalcitol in Postmenopausal Japanese Women with Osteoporosis
по: Junichi Takada, и др.
Опубликовано: (2016-12-01)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
по: Philip Sambrook
Опубликовано: (2007-04-01)

Ibandronate: The loading dose concept in the treatment of metastatic bone pain
по: Gerrit Steffen Maier, и др.
Опубликовано: (2016-03-01)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
по: Allan Lipton
Опубликовано: (2011-03-01)

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
по: Mabilleau, G, и др.
Опубликовано: (2011)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
по: Delmas, P, и др.
Опубликовано: (2005)

Administration of PTH and ibandronate increases ovariectomized rat compact bone viscoelasticity
по: Yang, Xiao, и др.
Опубликовано: (2013)

Case series: Chemical pneumonitis caused by exposure of sodium ibandronate powder
по: Ting Pan, и др.
Опубликовано: (2025-02-01)

Influence of ibandronate therapy on homocysteine and leptin levels in postmenopausal women with osteoporosis
по: Tat'yana Sergeevna Borodich
Опубликовано: (2015-12-01)

Clinical advantage and tolerability of ibandronate in hemodialysis patients: a retrospective study
по: Satoru Mitsuboshi, и др.
Опубликовано: (2018-01-01)

Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis.
по: Zeren Ma, и др.
Опубликовано: (2016-01-01)

Local application of ibandronate/gelatin sponge improves osteotomy healing in rabbits.
по: Zongyou Yang, и др.
Опубликовано: (2015-01-01)

Preparation and Properties of New Co-Crystals of Ibandronate with Gluco- or Galactopyranoside Derivatives
по: Jiri Dohnal, и др.
Опубликовано: (2010-12-01)

Avalanche character and fatalities in the high mountains of Asia
по: D.M. McClung
Опубликовано: (2016-01-01)